Abstract
Hepatocellular carcinoma (HCC) is the most common primary hepatic tumor. Globally, HCC is one of the most common malignant visceral tumors (1,2), with more than 350,000 cases reported every year (1). Annual incidence rate in North and South America for HCC is 2–4 cases per 100,000 persons (1). The worldwide distribution of HCC is closely linked to the prevalence of hepatitis B infection. There is a 200-fold increased risk of HCC in adults who become hepatitis B virus (HBV) carriers during infancy as a result of vertical transmission from the infected mother (3). HCC in this population frequently occurs without coincident cirrhosis (in approx 50% cases) and at a younger age—often between 20 and 40 years (1). In contrast, cirrhosis is present in 85–90% cases of HCC in the Western population (low-incidence region), where HBV is not prevalent. The most common associations with HCC in this region are alcohol and chronic infection with hepatitis C virus (HCV) (1); rarely does it occur before age 60 years (1). Males outnumber females in the distribution of HCC in both the high- and low-incidence regions; the male/female ratio is 8:1 in the high-incidence population and 2:1 to 3:1 in the low-incidence population (1,2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Crawford JM. The liver and the biliary tract. In: Pathologic Basis of Disease, 6th ed. (Cotran RS, Kumar V, Collins T, eds.), WB Saunders, Philadelphia, 1999, pp. 888–891.
del Pilar Fernandez M, Redvanley RD. Primary hepatic malignant neoplasms. Radiol Clin North Am 1998;36:333–348.
Beasley RP. Hepatitis B virus, the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942–1956.
Baron RL, Oliver JH III, Dodd GD III, et al. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced helical CT. Radiology 1996;199:505–511.
Oliver JH III, Baron RL, Federle MP, et al. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. Am J Roentgenol 1996;167:71–77.
Kanematsu M, Oliver JH III, Baron RL, et al. Hepatocellular carcinoma: the role of biphasic contrast-enhanced CT versus CT during arterial portography. Radiology 1997;205:75–80.
Kanematsu M, Hoshi H, Murakami T, et al. Detection of hepatocellular carcinoma in patient with cirrhosis: MR imaging versus angiographically assisted helical CT. Am J Roentgenol 1997;169:1507–1515.
Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangoafodipir trisodium (MnDPDP). Radiology 1996;200:69–77.
Shimamoto K, Sakuma S, Ishigaki T. Hepatocellular carcinoma: evaluation with color Doppler US and MR imaging. Radiology 1992;182:149–153.
Kudo M, Tomita S, Tochio H, et al. Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992;182:155–160.
Kudo M, Tomita S, Tochio H, et al. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. Am J Roentgenol 1992;158:65–74.
Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298–304.
Takayasu K, Shima Y, Muramatsu Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987;162:345–351.
Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989;170:783–786.
Sironi S, Cobelli F, Livraghi Y, et al. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology 1994;192:407–412.
Liang HL, Yang FC, Pan HB, et al. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. Radiology 2000;214:769–774.
Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67–72.
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397–401.
Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993;188:79–83.
Dodd GD III, Frank M, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. Am J Roentgenol 2001;177:777–782.
Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. Am J Roentgenol 2001;177:783–788.
Numata K, Tanaka K, Kiba T, et al. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO2-enhanced sonography. Am J Roentgenol 2001;177:789–798.
Hanson PS, Soulen MC. Tumor ablation: a review of techniques and outcomes. Suppl Applied Radiol 2001;30:70–81.
Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 1995;197:812–818.
Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Cancer 1992;69:925–929.
Sugiura N, Takara K, Ohto M, Okuda K, Hirooka N. Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 1983;24:920–923.
Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986;161:309–312.
Ohnishi K, Chin N, Ito S. Percutaneous acetic acid injection therapy for hepatocellular carcinoma less than 3 cm in diameter [in Japanese]. Acta Hepatol Jpn 1993;34:504–516.
Ebara M, Ohto M, Sugiura N, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: study of 95 patients. J Gastroenterol Hepatol 1990;5:616–626.
Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–108.
Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995;194:113–118.
Bartolozzi C, Lencioni Ricci P, Paolicchi A, Rossi A, Passariello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast-enhanced color Doppler US. Radiology 1998;209:387–393.
Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67–72.
Lee MJ, Mueller PR, Dawson SL, et al. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique and efficacy. Am J Roentgenol 1995;164:215–220.
Okuda K, Musha H, Nakajima J, et al. Clinicopathological features of encapsulated hepatocellular carcinoma: a study of 26 cases. Cancer 1977;40:1240–1245.
Nakajima O. Pathological study on early hepatocellular carcinoma—a study of capsule and septum formation [in Japanese]. Acta Hepatol Jpn 1989;30:28–34.
Torimura T, Mechanism of the fibrous capsular formation surrounding hepatocellular carcinoma—immunohistochemical analysis [in Japanese]. Acta Hepatol Jpn 1989;30:1596–1605.
Joseph FB, Baumgartner DA, Bernardiino ME. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy. Radiology 1993;186:553–556.
Revandly RD, Chezmar JL. Percutaneous ethanol ablation therapy of malignant hepatic tumors using CT guidance. Semin Intervent Radiol 1993;10:82–87.
Lencioni R, Caramella D, Bartolozzi C. Response of hepatocellular carcinoma to percutaneous ethanol injection: CT and MR evaluation. J Comput Assist Tomogr 1993;17:723–729.
Hashimoto M., Watanabe O, Hirano Y, Kato K, Watarai J. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma. Am J Roentgenol 1997;169:1307–1310.
Livraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 1991;179:709–712.
Ohnishi K, Ohyama N, Ito S, Fujiwara K. Ultrasound guided intratumor injection of acetic acid for the treatment of small hepatocellular carcinoma. Radiology 1994;193:747–752.
Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993;160:1023–1028.
Cedrone A, Rapaccini GL, Pompili M, Grattagliano A, Aliotta A, Trombino C. Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma. Radiology 1992;183:787,788.
Ishii H, Okada S, Okusaka T, Yoshimori M. Needle track implantation of hepatocellular carcinoma after ethanol injection. Cancer 1998;82:1638–1642.
Zerbey A, Mueller PR, Dawson S, Hoover HC Jr. Pleural seeding from hepatocellular carcinoma: a complication of percutaneous alcohol ablation. Radiology 1994;193:81,82.
Sumi S, Yamashita Y, Mitsuzaki K, et al. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. Am J Roentgenol 1999;172:67–71.
Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazella GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience. Radiology 1999;211:643–649.
Sironi S, Cobelli FD, Livraghi T, et al. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology 1994;192:407–412.
Nagel HS, Bernardino ME. Contrast enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy. Radiology 1993;189:265–270.
Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150–1153.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Kapoor, V., Thaete, F.L. (2005). Percutaneous Ethanol and Acetic Acid Ablation of Hepatocellular Carcinoma. In: Carr, B.I. (eds) Hepatocellular Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-844-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-59259-844-1_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-125-7
Online ISBN: 978-1-59259-844-1
eBook Packages: MedicineMedicine (R0)